These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2447735)

  • 1. [An experimental study of serum interferons in chronic myelogenous leukemia].
    Tsuchikawa K; Sato I; Suzuki C; Watanabe Y
    Nihon Ketsueki Gakkai Zasshi; 1987 May; 50(3):589-97. PubMed ID: 2447735
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunophenotyping in acute leukaemia, myelodysplastic syndromes and hairy cell leukaemia. The use of monoclonal antibodies against myeloid differentiation antigens.
    Kristensen JS
    Dan Med Bull; 1994 Feb; 41(1):52-65. PubMed ID: 8187565
    [No Abstract]   [Full Text] [Related]  

  • 3. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia.
    Wood BL
    Clin Lab Med; 2007 Sep; 27(3):551-75, vii. PubMed ID: 17658407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
    Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ
    Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of inhibitory activity derived from leukemic cells and its use in clinical practice].
    Cukrová V; Neuwirtová R; Novák F; Cermák J
    Vnitr Lek; 1987 Mar; 33(3):241-7. PubMed ID: 3499031
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytomegalovirus infection with acute myelocytic leukemia; antiviral (interferon and antibody) responses.
    O'Malley JA; al-Bussam N; Beutner K; Wallace HJ; Gailani S; Henderson ES; Carter WA
    N Y State J Med; 1975 Apr; 75(5):738-42. PubMed ID: 164640
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine].
    Waage A; Hammerstrøm J; Lødemel B; Hoff JE; Langtind J
    Tidsskr Nor Laegeforen; 1986 Feb; 106(6):496-7. PubMed ID: 3457484
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
    Bruserud O; Ulvestad E
    Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon production in myelo- and lymphoproliferative diseases. I. Spontaneous interferon production in acute and chronic leukaemias.
    Szabó B; Tóth FD; Kiss J; Váczi L; Kiss A; Rák K
    Acta Microbiol Hung; 1988; 35(3):295-300. PubMed ID: 2465655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Philadelphia chromosome positive myelodysplastic syndrome and acute myelogenous leukemia.
    Advani AS
    Leuk Res; 2004 Jun; 28(6):545-6. PubMed ID: 15120928
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical investigation of interferons in the preleukemic state (CML and MDS)].
    Koyama S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1191-7. PubMed ID: 3132893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties and usefulness of the original K-562 human myelogenous leukemia cell line.
    Lozzio BB; Lozzio CB
    Leuk Res; 1979; 3(6):363-70. PubMed ID: 95026
    [No Abstract]   [Full Text] [Related]  

  • 13. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
    Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
    Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stimulating capacity of leukemia cells from acute non-lymphocytic leukemia, chronic myelogenous leukemia, blastic crisis of chronic myelogenous leukemia, and chronic myelomonocytic leukemia in allogenic 'one way' mixed lymphocyte tumor cell reaction (author's transl)].
    Saito H; Minato K; Nagatani T; Shimoyama M
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):796-804. PubMed ID: 6453495
    [No Abstract]   [Full Text] [Related]  

  • 15. Absent serum interferon in chronic lymphatic leukemia.
    Ludwig H
    N Engl J Med; 1979 Nov; 301(18):1007. PubMed ID: 492224
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
    Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
    Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of lysolecithin on chronic myelogenous leukemia cells. I].
    Murata T; Oniki H; Komoda T; Komori T; Tanaka T; Murata K; Koga Y
    Igaku Kenkyu; 1981 Dec; 51(5):270-4. PubMed ID: 6958149
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction and production of human interferon with human leukemic cells.
    Hershberg RD; Gusciora EG; Familletti PC; Rubinstein S; Rose CA; Pestka S
    Methods Enzymol; 1981; 78(Pt A):45-8. PubMed ID: 6173628
    [No Abstract]   [Full Text] [Related]  

  • 20. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
    Boultwood J; Pellagatti A; Watkins F; Campbell LJ; Esoof N; Cross NC; Eagleton H; Littlewood TJ; Fidler C; Wainscoat JS
    Br J Haematol; 2004 Aug; 126(4):508-11. PubMed ID: 15287943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.